http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022211544-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3164a963ca21cec1151213cb1bb95e77 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate | 2022-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b61db32e1258bc04ad14bcf4948600ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8d52ab7d94126f22711f68c03598b72 |
| publicationDate | 2022-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2022211544-A1 |
| titleOfInvention | Regulatory t cell-derived peptide and composition including same for prevention or treatment of autoimmune disease |
| abstract | The present invention relates to a composition for prevention or treatment of autoimmune disease, which is based on a CTLA4-derived peptide of regulator T cells. The composition has an excellent effect of inhibiting differentiation into cytotoxic Th17 cells that produce and secrete inflammatory cytokines and increasing differentiation into regulatory T cells (Treg) and thus can be advantageously utilized as a pharmaceutical composition that can prevent or treat autoimmune diseases caused by regulatory anomalies of various immune responses. |
| priorityDate | 2021-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 241.